 |
Dextroamphetamine - Therapeutic use
Research News and Information
Definition of 'Dextroamphetamine'The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic. |
Saturday, November 21, 2009
The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD.
29 Apr 2009 
Pharmacotherapy plays a primary role in the management of attention-deficit/hyperactivity disorder (ADHD), despite the availability of effective behavioral interventions. Psychostimulants are the most commonly prescribed form of pharmacotherapy for ... Read more...
Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.
29 Apr 2009 Although symptoms of attention-deficit/ hyperactivity disorder (ADHD) are certainly most visible in children, the syndrome persists into adolescence in 40% to 70% of cases and into adulthood in 50% or more of cases. Accurate recognition of the ... Read more...
Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults.
27 Feb 2009 
BACKGROUND: Symptoms of attention-deficit hyperactivity disorder (ADHD) are known to persist into adulthood in the majority of cases. AIMS: To determine the prevalence of methylphenidate, dexamfetamine and atomoxetine prescribing and treatment ... Read more...
Latest indexed articles for 'Dextroamphetamine - Therapeutic use'
These are the very latest articles for this heading:
- The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD. 29 Apr 2009
- Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting. 29 Apr 2009
- Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. 27 Feb 2009
- Is there a role for psychostimulants in old age depression and apathy?
14 Feb 2009 - Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. 30 Jan 2009
- Lisdexamfetamine dimesylate: in attention-deficit hyperactivity disorder in adults. 30 Dec 2008
- Stimulant treatment of frontotemporal dementia in 8 patients. 29 Nov 2008
- Poststroke treatment: lost in translation. 24 Nov 2008
- Illicit use of prescription ADHD medications on a college campus: a multimethodological approach. 30 Oct 2008
- Sex differences in cognitive estimation during sleep deprivation: effects of stimulant countermeasures. 30 Oct 2008
- Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy. 13 Oct 2008
- A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. 12 Sep 2008
- Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysis. 30 Aug 2008
- Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil. 30 Aug 2008
- Lisdexamfetamine: a prodrug stimulant for ADHD. 30 Jul 2008
- Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. 29 Jun 2008
- Apathy associated with Alzheimer disease: use of dextroamphetamine challenge. 29 Jun 2008
- Pharmacological modulation of cortical plasticity following kainic acid lesion in rat barrel cortex. 29 Jun 2008
- Attention deficit/hyperactivity disorder: a review and update. 18 Jun 2008
- Response to Brasic (2007): psychomotor study of children with ADHD. 30 May 2008
See a longer list of these articles.
Technical information about 'Dextroamphetamine'
Definition: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
Chemical name: Benzeneethanamine, alpha-methyl-, (S)-
Registry Number: 51-64-9
Descriptor UI: D003913
Alternative terms: Dextroamphetamine; dextro-Amphetamine; dextro Amphetamine; Dexamphetamine; d-Amphetamine; d Amphetamine; Dexamfetamine; Oxydess; Vortech Brand of Dextroamphetamine Sulfate; Dextroamphetamine Sulfate; Sulfate, Dextroamphetamine; d-Amphetamine Sulfate; d Amphetamine Sulfate; Dextro-Amphetamine Sulfate; Dextro Amphetamine Sulfate; DextroStat; Shire Brand of Dextroamphetamine Sulfate; Curban; Pasadena Brand of Dextroamphetamine; Dexedrine; GlaxoSmithKline Brand of Dextroamphetamine Sulfate; Mallinckrodt Brand of Dextroamphetamine Sulfate; Celltech Brand of Dextroamphetamine Sulfate;
Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Pharmacological Action: Dopamine Uptake Inhibitors; Central Nervous System Stimulants;
Tree Number: D02.092.471.683.152.110.200;
Online Note: use DEXTROAMPHETAMINE to search DEXTRO AMPHETAMINE 1966-76
History Note: 77; was DEXTRO AMPHETAMINE 1963-76